Clinical trial
GPI 15715 For Sedation in the Intensive Care Unit (ICU) Setting
NCT00125398 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00125398 |
|---|---|
| Title | GPI 15715 For Sedation in the Intensive Care Unit (ICU) Setting |
| Official title | A Phase II, Randomized, Open-Label Study to Examine the Safety and Efficacy of GPI 15715 for Sedation of Patients Requiring Intubation and Mechanical Ventilation in the Intensive Care Unit Setting |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Postoperative Sedation, Intubation, Respiration, Artificial |
| Intervention type | Drug |
| Interventions | AQUAVAN (fospropofol disodium, GPI 15715 ) |
| Enrollment | 60 |
| Start date | Jul 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Aug 1, 2005 |
| Last update posted | Nov 7, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: